Benzinga | Nov 12, 2020 07:29AM EST

ArTara Therapeutics Q3 EPS $(1.26) Down From $(0.92) YoY

ArTara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(1.26) per share. This is a 36.96 percent decrease over losses of $(0.92) per share from the same period last year.